BRIEF published on 04/21/2026 at 15:14, 19 days 20 hours ago MaaT Pharma SACA maintient sa recommandation d'achat avec des perspectives financières stables Performance Financière Développement De Pipelines MaaT Pharma Dossier D'investissement Évaluation D'achat
BRIEF published on 04/21/2026 at 15:14, 19 days 20 hours ago MaaT Pharma SACA Maintains Buy Rating with Stable Financial Outlook Financial Performance BUY Rating Pipeline Development MaaT Pharma Investment Case
PRESS RELEASE published on 04/21/2026 at 15:09, 19 days 20 hours ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research reaffirms Buy rating for MaaT Pharma SACA with a target price of €17 following FY25 results and pipeline update. No changes to core investment case First Berlin Equity Research BUY Rating MaaT Pharma SACA FY25 Results €17 Target Price
BRIEF published on 04/01/2026 at 07:35, 1 month 10 days ago MaaT Pharma publishes data on aGvH in "Bone Marrow Transplantation" MaaT Pharma EMA AGvH Xervyteg® CHRONOS
BRIEF published on 04/01/2026 at 07:35, 1 month 10 days ago MaaT Pharma Presents CHRONOS Study Results on Third-Line Acute GvHD MaaT Pharma Regulatory Review CHRONOS Study Acute GvHD Third-line Therapy
BRIEF published on 04/01/2026 at 07:35, 1 month 10 days ago MaaT Pharma présente les résultats de l'étude CHRONOS sur le traitement de troisième ligne de la GVHD aiguë MaaT Pharma Examen Réglementaire Étude CHRONOS GVHD Aiguë Traitement De Troisième Ligne
BRIEF published on 04/01/2026 at 07:35, 1 month 10 days ago MaaT Pharma publie des données sur l'aGvH dans "Bone Marrow Transplantation" MaaT Pharma EMA AGvH Xervyteg® CHRONOS
PRESS RELEASE published on 04/01/2026 at 07:30, 1 month 10 days ago Informations privilégiées / Autres communiqués MaaT Pharma publie des données rétrospectives de l'étude CHRONOS sur la maladie aiguë du greffon contre l'hôte (aGvH) dans Bone Marrow Transplantation. Résultats présentés au congrès annuel 2026 de l'EBMT MaaT Pharma Étude Bone Marrow Transplantation CHRONOS Maladie Aiguë Du Greffon Contre L'hôte
PRESS RELEASE published on 04/01/2026 at 07:30, 1 month 10 days ago Inside Information / Other news releases MaaT Pharma announces publication of retrospective data from CHRONOS study in Bone Marrow Transplantation Journal, presenting real-world outcomes of third-line systemic treatments for GI-aGvHD patients MaaT Pharma GI-aGvHD CHRONOS Study Retrospective Data Bone Marrow Transplantation
BRIEF published on 03/31/2026 at 07:35, 1 month 11 days ago MaaT Pharma: 2025 Revenue and Clinical Progress Revenue Funding Clinical Development MaaT Pharma Microbiothérapies
Published on 05/11/2026 at 09:05, 2 hours 43 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 3 hours 43 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:30, 2 days 10 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/11/2026 at 11:36, 12 minutes ago LION Smart and LEAPENERGY secure the performance of their storage containers through multiple guarantees
Published on 05/11/2026 at 11:17, 31 minutes ago Aroundtown SA: Release of a capital market information
Published on 05/11/2026 at 11:10, 38 minutes ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Published on 05/11/2026 at 11:09, 39 minutes ago Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Published on 05/11/2026 at 10:48, 1 hour ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 1 hour ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 2 hours 32 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 16 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 16 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
